#OIS2016 - Twitter Hashtag

Yoselin Vieira @yoselin_vieira

almost 10 years ago

Costume Day! Thank for the show @magomontii #ois2016 #lovemyjob #teacherteam #magicshow https://t.co/REz1bu4jgj

0

Rich Kirkner @rmkeditor

almost 10 years ago

pSivida's Medidur for uveitis has potential to achieve $100M savings over 5 years, Pres/CEO Nancy Lurker reports at #ois2016 @OISTWEETS

0

1

0

Rich Kirkner @rmkeditor

almost 10 years ago

Michael Lachman of EyeQ Research introduces OIS Index of mid- & small-cap ophthalmic companies at #OIS2016 @OISTWEETS

0

1

0

Eyewire+ @eyewireplus

almost 10 years ago

Jim Mazzo of #ZEISS: Innovation/entrepreneurial spirit at small company is what I would love to bring to large company. #OIS2016 #AAO2016

0

1

0

Rich Kirkner @rmkeditor

almost 10 years ago

CZM's James Mazzo at #OIS2016: "The minute you start to think US and ex- US … you begin to lose leverage across markets." @OISTWEETS

0

1

0

Eyewire+ @eyewireplus

almost 10 years ago

Ashley McEvoy of @JNJ says key to growth is to stay lean and agile, and customer focused. #OIS2016 #AAO2016

0

1

0

Eyewire+ @eyewireplus

almost 10 years ago

Bob Dempsey of #Shire says the company's ophthalmics division is well positioned for growth in US and globally. #OIS2016 #AAO2016

0

2

0

Eyewire+ @eyewireplus

almost 10 years ago

@EyeWireToday is filming live at the OIS meeting! Be sure to watch #EyewireTV next week for a full roundup. #OIS2016 #AAO2016

eyewireplus's tweet photo. @EyeWireToday is filming live at the OIS meeting! Be sure to watch #EyewireTV next week for a full roundup. #OIS2016 #AAO2016 https://t.co/hi2qwM73Oa

0

1

0

The Ophthalmologist @OphthoMag

almost 10 years ago

Quentin Oswald of Notal Vision. Using the cloud and telemonitoring to leverage home-based detection of retinal diseases #oisaao #ois2016

OphthoMag's tweet photo. Quentin Oswald of Notal Vision. Using the cloud and telemonitoring to leverage home-based detection of retinal diseases #oisaao #ois2016 https://t.co/4JPu1HbxaL

1

0

The Ophthalmologist @OphthoMag

almost 10 years ago

Ocular Therapeutix showing that their depot formulations of antibodies have activity out to 26 weeks #OISAAO #OIS2016

0

2

0

John Hall @johnhallnj

almost 10 years ago

#OIS2016 $OCUL deal with $REGN goal is simple. Decrease # of injections

1

2

1

0

The Ophthalmologist @OphthoMag

almost 10 years ago

Luminate Del Mar US Phase IIb study patient examples #OCT #OIS2016

0

1

0

The Ophthalmologist @OphthoMag

almost 10 years ago

Vicken Karageozean - Allegro - Luminate Phase II data presented today for the first time #OIS2016

1

0

1

0

The Ophthalmologist @OphthoMag

almost 10 years ago

@OphthoMag Zuprata plus Eylea = 60% fewer injections than Stela alone (at 3 months). #OIS2016 [Clearside biomedical]

0

The Ophthalmologist @OphthoMag

almost 10 years ago

Monty Montoya - SightLife Surgical - corneal transplant market is small and fragmented. SLS is going to take this on "aggressively" #OIS2016

OphthoMag's tweet photo. Monty Montoya - SightLife Surgical - corneal transplant market is small and fragmented. SLS is going to take this on "aggressively" #OIS2016 https://t.co/hXE4m0sIXf

1

2

0

The Ophthalmologist @OphthoMag

almost 10 years ago

Chris Geddes presents the second generation of LacriPen - a portable osmometer - DED, MMP-9, HSV etc diagnostic pen. #OIS2016 #LacriScience

OphthoMag's tweet photo. Chris Geddes presents the second generation of LacriPen - a portable osmometer - DED, MMP-9, HSV etc diagnostic pen. #OIS2016 #LacriScience https://t.co/iJf6zfi9Dl

1

0

The Ophthalmologist @OphthoMag

almost 10 years ago

... and the effects of LipiFlow last up to 12 months, and also in CL and cataract patients too #OIS2016

0

1

0

The Ophthalmologist @OphthoMag

almost 10 years ago

TearScience's Joe Boorady presents on the benefits of LipiFlow and details the MGD market size. #OIS2016

1

2

1

0

The Ophthalmologist @OphthoMag

almost 10 years ago

@OphthoMag Triggerfish data might be predictive of glaucoma outcomes. Sensimed have always been "big data" https://t.co/xvHwWl6UhF #ois2016

0

1

0

The Ophthalmologist @OphthoMag

almost 10 years ago

David Bailey, CEO of Sensimed on stage at #OIS2016 - FDA has approved Triggerfish. Describes it as a "Sleep lab without hospitalization"

OphthoMag's tweet photo. David Bailey, CEO of Sensimed on stage at #OIS2016 - FDA has approved Triggerfish. Describes it as a "Sleep lab without hospitalization" https://t.co/ZxZQispFMQ

1

0

Top Tweets for #OIS2016

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users